These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22750096)

  • 1. Inhibition of HSP70: a challenging anti-cancer strategy.
    Goloudina AR; Demidov ON; Garrido C
    Cancer Lett; 2012 Dec; 325(2):117-24. PubMed ID: 22750096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting heat shock proteins in cancer.
    Jego G; Hazoumé A; Seigneuric R; Garrido C
    Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.
    Xu W; Neckers L
    Clin Cancer Res; 2007 Mar; 13(6):1625-9. PubMed ID: 17363512
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
    Wang Y; McAlpine SR
    Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
    Wang X; Chen M; Zhou J; Zhang X
    Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hsp90--a target for anticancer therapy].
    Růcková E; Müller P; Vojtesek B
    Klin Onkol; 2011; 24(5):329-37. PubMed ID: 22070013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hop: more than an Hsp70/Hsp90 adaptor protein.
    Odunuga OO; Longshaw VM; Blatch GL
    Bioessays; 2004 Oct; 26(10):1058-68. PubMed ID: 15382137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of heat shock proteins as regulators of apoptosis and innate immunity.
    Joly AL; Wettstein G; Mignot G; Ghiringhelli F; Garrido C
    J Innate Immun; 2010; 2(3):238-47. PubMed ID: 20375559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein chaperones as anticancer therapy targets.
    Sausville E
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):92-3. PubMed ID: 16163168
    [No Abstract]   [Full Text] [Related]  

  • 12. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
    Håvik B; Bramham CR
    Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp70: anti-apoptotic and tumorigenic protein.
    Rérole AL; Jego G; Garrido C
    Methods Mol Biol; 2011; 787():205-30. PubMed ID: 21898238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp70: A Cancer Target Inside and Outside the Cell.
    Boudesco C; Cause S; Jego G; Garrido C
    Methods Mol Biol; 2018; 1709():371-396. PubMed ID: 29177673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.
    Shevtsov M; Multhoff G; Mikhaylova E; Shibata A; Guzhova I; Margulis B
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
    Perego P; Cossa G; Zuco V; Zunino F
    Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to assay molecular chaperone activity of HSP70: evaluation of drug resistance in cancer treatment.
    Ding X; Li H; Xie H; Huang Y; Hou Y; Yin Y; Li G
    Biosens Bioelectron; 2013 Sep; 47():75-9. PubMed ID: 23562728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
    Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
    Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATPases as drug targets: insights from heat shock proteins 70 and 90.
    Massey AJ
    J Med Chem; 2010 Oct; 53(20):7280-6. PubMed ID: 20608738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.